Dihydroartemisinin down-regulates the expression of transferrin receptor in myeloid leukemia cells

Yaoxue Xuebao

Volumn 43, Issue 6, 2008, Pages 576-583

  Wang, Zeng ^a   Zhou, Hui Jun ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Dihydroartemisinin; HL60 cell; Holotransferrin; K562 cell; Transferrin receptor

Indexed keywords

ANTINEOPLASTIC AGENT; ARTEMISININ DERIVATIVE; DIHYDROQUINGHAOSU; HOLOTRANSFERRIN; MESSENGER RNA; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN K 562; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; GENETICS; HUMAN; METABOLISM;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARTEMISININS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HL-60 CELLS; HUMANS; K562 CELLS; RECEPTORS, TRANSFERRIN; RNA, MESSENGER; TRANSFERRIN;

EID: 49049109852     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Tracy RD, Tracie D, Jose AR, et al. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer [J]. Clin Immunol, 2006,121:144-158.
2. Ng PP, Dela Cruz JS, Sorour DN, et al. An antitransferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells [J]. Proc Natl Acad Sci USA, 2002,99:10706-10711.
3. Trowbridge IS, Domingo DL. Anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates affect growth of human tumour cells [J]. Nature, 1981,294:171-173.
4. Domingo DL, Trowbridge IS. Transferrin receptor as a target for antibody-drug conjugates [J]. Methods Enzymol, 1985,112:238-247.
5. Efferth T, Dunstan H, Sauerbrey A, et al. The anti-malarial artesunate is also active against cancer [J]. Int J Oncol, 2001,18:767-773.
6. Li J, Zhou HJ. Dihydroartemisinin in inhibits the expression of vascular endothelial growth factor in K562 cells [J]. Acta Pharm Sin, 2005,40:1041-1045.
7. Moore JC, Lai H, Li JR, et al. Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat [J]. Cancer Lett, 1995, 98:83-87.
8. Efferth T, Olbrich A, Bauer R. mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether [J]. Biochem Pharmacol, 2002,64:617-623.
9. Chen HH, Zhou HJ, Fang X. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro [J]. Pharmacol Res, 2003,48:231-236.
10. Lee J, Zhou HJ, Wu XH. Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells [J]. Cancer Chemother Pharmacol, 2006,57:213-220.
11. Li A, Zhou HJ. Apoptosis of HL-60 cells induced by dihydroartemisinin [J]. Chin J Pharmacol Toxicol, 2007,21:217-222.
12. Kim SJ, Kim MS, Lee JW, et al. Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro [J]. J Cancer Res Clin Oncol, 2006,132:129-135.
13. Lai H, Sasaki T, Singh NP. Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds [J]. Expert Opin Ther Targets, 2005,9:995-1007.
14. Efferth T, Benakis A, Romero MR. et al. Enhancement of cytotoxicity of artemisinin toward cancer cells by ferrous iron [J]. Free Radic Biol Med, 2004,37:998-1009.
15. Li W, Mo W, Shen D, et al. Yeast model uncovers dual roles of mitochondria in action of arteminsinin [J]. PLoS Genet, 2005,1:330-334.
16. Keer HN, Kozlowski JM, Tsai YC, et al. Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo [J]. J Urol, 1990,143:381-385.
17. Taetle R. The role of transferrin receptors in hemopoietic cell growth [J]. Exp Hematol, 1990,18:360-365.
18. Lloyd JM, O'Dowd T, Driver M, et al. Demonstration of an epitope of the transferrin receptor in human cervical epithelium - a potentially useful cell marker [J]. J Clin Pathol, 1984,37:131-135.
19. Yang DC, Wang F, Elliott RL, et al. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer [J]. Anticancer Res, 2001,21:541-549.
20. Amy EM, James LM, Sun XM, et al. Evidence for the involvement of canbon-centered radicals in the induction of aopototic cell death by artemisinin compounds [J]. J Biol Chem, 2007,282:9372-9382.
21. Wang W, Di X, D'Agostino RB Jr, et al. Excess capacity of the iron regulatory protein system [J]. J Biol Chem, 2007,282:24650-24659.
22. Tu YY. The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu [J]. Chin Med J, 1999,112:976-977.